234 related articles for article (PubMed ID: 36762418)
1. Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome.
Stiburkova B; Pavelcova K; Belickova M; Magaziner SJ; Collins JC; Werner A; Beck DB; Balajkova V; Salek C; Vostry M; Mann H; Vencovsky J
Arthritis Rheumatol; 2023 Jul; 75(7):1285-1290. PubMed ID: 36762418
[TBL] [Abstract][Full Text] [Related]
2. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Ferrada MA; Savic S; Cardona DO; Collins JC; Alessi H; Gutierrez-Rodrigues F; Kumar DBU; Wilson L; Goodspeed W; Topilow JS; Paik JJ; Poulter JA; Kermani TA; Koster MJ; Warrington KJ; Cargo C; Tattersall RS; Duncan CJA; Cantor A; Hoffmann P; Payne EM; Bonnekoh H; Krause K; Cowen EW; Calvo KR; Patel BA; Ombrello AK; Kastner DL; Young NS; Werner A; Grayson PC; Beck DB
Blood; 2022 Sep; 140(13):1496-1506. PubMed ID: 35793467
[TBL] [Abstract][Full Text] [Related]
3. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
[TBL] [Abstract][Full Text] [Related]
4. Somatic Mutations in
Beck DB; Ferrada MA; Sikora KA; Ombrello AK; Collins JC; Pei W; Balanda N; Ross DL; Ospina Cardona D; Wu Z; Patel B; Manthiram K; Groarke EM; Gutierrez-Rodrigues F; Hoffmann P; Rosenzweig S; Nakabo S; Dillon LW; Hourigan CS; Tsai WL; Gupta S; Carmona-Rivera C; Asmar AJ; Xu L; Oda H; Goodspeed W; Barron KS; Nehrebecky M; Jones A; Laird RS; Deuitch N; Rowczenio D; Rominger E; Wells KV; Lee CR; Wang W; Trick M; Mullikin J; Wigerblad G; Brooks S; Dell'Orso S; Deng Z; Chae JJ; Dulau-Florea A; Malicdan MCV; Novacic D; Colbert RA; Kaplan MJ; Gadina M; Savic S; Lachmann HJ; Abu-Asab M; Solomon BD; Retterer K; Gahl WA; Burgess SM; Aksentijevich I; Young NS; Calvo KR; Werner A; Kastner DL; Grayson PC
N Engl J Med; 2020 Dec; 383(27):2628-2638. PubMed ID: 33108101
[TBL] [Abstract][Full Text] [Related]
5. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
[TBL] [Abstract][Full Text] [Related]
7. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
Kouranloo K; Dey M; Almutawa J; Myall N; Nune A
Rheumatol Int; 2024 Jul; 44(7):1219-1232. PubMed ID: 38129348
[TBL] [Abstract][Full Text] [Related]
9. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.
van der Made CI; Potjewijd J; Hoogstins A; Willems HPJ; Kwakernaak AJ; de Sevaux RGL; van Daele PLA; Simons A; Heijstek M; Beck DB; Netea MG; van Paassen P; Elizabeth Hak A; van der Veken LT; van Gijn ME; Hoischen A; van de Veerdonk FL; Leavis HL; Rutgers A
J Allergy Clin Immunol; 2022 Jan; 149(1):432-439.e4. PubMed ID: 34048852
[TBL] [Abstract][Full Text] [Related]
10. A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment.
Tozaki N; Tawada C; Niwa H; Mizutani Y; Shu E; Kawase A; Miwa Y; Ohnishi H; Sasai H; Miyako K; Hosokawa J; Kato A; Kobayashi K; Miyazaki T; Shirakami Y; Shimizu M; Iwata H
Front Med (Lausanne); 2022; 9():1046820. PubMed ID: 36544501
[TBL] [Abstract][Full Text] [Related]
11. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
[TBL] [Abstract][Full Text] [Related]
12. VEXAS-Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort.
Corty RW; Brogan J; Byram K; Springer J; Grayson PC; Bick AG
Arthritis Rheumatol; 2024 Jun; 76(6):942-948. PubMed ID: 38225170
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
[TBL] [Abstract][Full Text] [Related]
14. UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
Shaukat F; Hart M; Burns T; Bansal P
Mod Rheumatol Case Rep; 2022 Jan; 6(1):134-139. PubMed ID: 34480172
[TBL] [Abstract][Full Text] [Related]
15. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report.
Fukuda N; Kanai D; Hoshino K; Fukuda Y; Morita R; Ishikawa Y; Kanaoka T; Toya Y; Kirino Y; Wakui H; Tamura K
BMC Nephrol; 2024 Jan; 25(1):18. PubMed ID: 38212709
[TBL] [Abstract][Full Text] [Related]
16. VEXAS syndrome in dermatology.
Afsahi V; Christensen RE; Alam M
Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
[TBL] [Abstract][Full Text] [Related]
17. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Patel N; Dulau-Florea A; Calvo KR
Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
[TBL] [Abstract][Full Text] [Related]
18. VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
Huang H; Zhang W; Cai W; Liu J; Wang H; Qin T; Xu Z; Li B; Qu S; Pan L; Huang G; Gale RP; Xiao Z
Exp Hematol Oncol; 2021 Mar; 10(1):23. PubMed ID: 33741056
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic manifestations of VEXAS syndrome.
Groarke EM; Dulau-Florea AE; Kanthi Y
Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
[TBL] [Abstract][Full Text] [Related]
20. Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome.
Oganesyan A; Hakobyan Y; Terrier B; Georgin-Lavialle S; Mekinian A
Semin Hematol; 2021 Oct; 58(4):247-253. PubMed ID: 34802547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
